期刊文献+

CRISPR基因编辑技术研究进展及其在水生生物中的应用 被引量:3

Advances on CRISPR gene editing technologies and their applications in aquatic organisms
下载PDF
导出
摘要 CRISPR基因编辑技术主要包括CRISPR/Cas9技术和CRISPR/Cpf1技术,与以往的基因编辑技术相比,具有高效、简便、低廉等优点,因此在过去短短的几年里,该基因编辑技术被大量应用于拟南芥(Arabidopsis thaliana)、水稻(Oryza sativa)、小鼠(Mus musculus)、猪(Sus scrofa)等陆生生物基因编辑相关研究中。目前,该技术在水生生物中也得到了应用,如在模式生物与疾病模型的构建、基因功能解析与筛选、水生生物新品种选育、疾病控制及海洋药物研发等方面。在阐述CRISPR基因编辑技术相关结构、作用机制和与其它基因编辑技术比较的基础上,对其在水生生物多个方面的应用情况进行了综述,旨在为从事相关研究的科研工作者们提供帮助。 Editing technologies of CRISPR/Cas9 and CRISPR/Cpf1 are known as the third generation gene editing technologies.Compared with the previous gene editing technologies,such as Zinc-finger nuclease(ZFN)and Transcription activator-like effector(TALEN),the CRISPR/Cas9 technology and CRISPR/Cpf1 technology have many advantages,more efficient,simpler and cheaper.Therefore,in recent years,the two technologies have been extensively applied in researches of terrestrial organisms,for example,thale cress,mouse,rice,pig etc.By now,the two technologies have also been widely used in studies of aquatic organisms,including the construction of model organisms and disease models,analysis and selection of gene function,breeding as well as research and development of medicine and so on.In this paper,based on the introduction of relevant structure and mechanism of CRISPR gene editing technologies,their applications in researches of aquatic organisms were reviewed to supply references for relevant studies.
作者 马杭柯 孙金秋 徐莞媛 阎斌伦 高焕 MA Hang-ke;SUN Jin-qiu;XU Wan-yuan;YAN Bin-lun;GAO Huan(Jiangsu Key Laboratory of Marine Biotechnology,College of Marine Life and Fisheries, Huaihai Institute of Technology,Lianyungang 222005,China;Co-innovation Center of Jiangsu Marine Bio-industry Technology,Lianyungang 222005,China;Marine Resource Development Institute of Jiangsu(Lianyungang),Lianyungang 222005,China;Jiangsu Provincial Platform for Conservation and Utilization of Agricultural Germplasm,Nanjing 210014,China)
出处 《海洋渔业》 CSCD 北大核心 2018年第5期632-640,共9页 Marine Fisheries
基金 国家自然科学基金(31472282);江苏省高等学校自然科学研究重大项目(17KJA240001);江苏省六大人才高峰优秀创新团队项目(2016-HYGC-CXTD-004);连云港市“521”人才计划
关键词 基因编辑技术 CRISPR/Cas9 CRISPR/Cpf1 水生生物 研究进展 gene editing technology CRISPR/Cas9 CRISPR/Cpf1 aquatic organisms research progress
  • 相关文献

参考文献15

二级参考文献136

  • 1董永新,王跃祥,钱林溪,蒋璆,刘学飞,宋后燕.桔梗皂苷对斑马鱼心功能及胚胎发育的影响[J].中国临床药学杂志,2006,15(5):299-303. 被引量:10
  • 2Letamendia A, Quevedo C, Ibarbia I, et al. Development and validation of an automated high-throughput system for zebrafish in vivo screenings[J]. PLoS ONE, 2012, 7(5):e36690.
  • 3Lessman C A. The developing zebrafish (Danio rerio) : a verte- brate model for high-throughput screening of chemical libraries [J]. Birth Defects Res C Embryo Today, 2011, 93(3) :268.
  • 4Spomer W, Pfriem A, Alshut R, et al. High-throughput screen- ing of zebrafish embryos using automated heart detection and ima- ging[J]. J Lab Autom, 2012,17(6) :435.
  • 5Pardo-Martin C, Chang T, Koo B K, et al. High-throughput in vivo vertebrate screening[ J]. Nat Methods, 2010, 7(8) :634.
  • 6Barbazuk W B, Korf I, Kadavi C, et al. The syntenic relation- ship of the zebrafish and human genomes [ J ] Genome Res, 2000, 10(9) :1351.
  • 7Beliaeva N F, Kashirtseva V N, Medvedeva N V, et al. Zebrafishas a model system for biomedical studies [ J ]. Biomed Khim, 2009,3(4) :343.
  • 8Delvecchio C, Tiefenbach J, Krause H M. The zebrafish : a pow- erful platform for in vivo, HTS drug discovery [ J ]. Assay Drug Dev Technol, 2011, 9(4) :354.
  • 9Zon L I, Peterson R T. In vivo drug discovery in the zebrafish [J]. Nat Rev Drug Discov, 2005, 4(1) :35.
  • 10Makhija D T, Jagtap A G. Studies on sensitivity of zebrafish as a model organism for Parkinson disease: comparison with rat model [ J]. J Pharmacol Pharmacother, 2014, 5 ( 1 ) :39.

共引文献265

同被引文献21

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部